A recent study examined costs associated with asthma-related hospitalizations, emergency department and outpatient visits, and pharmaceutical use. The authors concluded that asthma is a high-cost chronic illness in employment-based populations, but these costs are concentrated in a small number of patients. Identifying and managing high-cost patients using strategies such as disease management may lead to cost savings. To view the article, visit http://www.medscape.com/viewarticle/465786 (requires free registration).
|
Printer Friendly 
